• Tidak ada hasil yang ditemukan

Supplementary Table 1 - http;//links.lww.com

N/A
N/A
Protected

Academic year: 2023

Membagikan "Supplementary Table 1 - http;//links.lww.com"

Copied!
2
0
0

Teks penuh

(1)

Supplementary Table 1: Parameters and distributions regarding recurrence and mortality for additional factors

Parameter Level Total Recurrence Mortality

No. (%) No. (%) pa No. (%) pa

Health care region b

Region 1 2779 (19) 437 (16) 0.883 966 (35) 0.012

Region 2 3106 (22) 504 (16) 1126 (36)

Region 3 1661 (12) 253 (15) 630 (38)

Region 4 2761 (19) 449 (16) 1076 (39)

Region 5 2709 (19) 448 (17) 1039 (38)

Region 6 1309 (9) 214 (16) 503 (38)

Age group 0-40 years 184 (1) 27 (15) 0.038 23 (13) 0. 000

40-50 years 442 (3) 74 (17) 56 (13)

50-60 years 1335 (9) 223 (17) 221 (17)

60-70 years 3677 (26) 618 (17) 825 (22)

70-80 years 5176 (36) 865 (17) 2036 (39)

80-90 years 3261 (23) 460 (14) 1993 (61)

90+ years 250 (2) 38 (15) 186 (74)

BMI c Underweight (<18.5) 336 (2) 53 (16) 0.098 197 (59) 0.000 Normal (18.5-24.9) 5323 (37) 837 (16) 2026 (38) Overweight (25-29.9) 4302 (30) 696 (16) 1361 (32)

Obese (30-34.9) 1519 (11) 218 (14) 476 (31)

Morbid obesity (>35) 439 (3) 82 (19) 148 (34)

Missing 2406 (17) 419 (17) 1132 (47)

ASA d I 2085 (15) 357 (17) 0.011 373 (18) 0.000

II 7318 (51) 1187 (16) 2324 (32)

III 3927 (27) 636 (16) 2151 (55)

IV and V 328 (2) 49 (15) 252 (77)

Missing 667 (5) 76 (11) 240 (36)

Pretherapeutic staging

No tumor staging 4337 (30) 725 (17) 0.180 1821 (42) 0.000

Tumor staged 9987 (70) 1580 (16) 3519 (35)

No lung staging 1750 (12) 349 (20) 0.000 799 (46) 0.000

Lung staged 12574 (88) 1956 (16) 4541 (36)

No liver staging 1489 (10) 279 (19) 0.003 673 (45) 0.000

Liver staged 12835 (90) 2026 (16) 4667 (36)

Vascular

ligature Central 8465 (59) 1353 (16) 0.000 3049 (36) 0.000

Distal 4603 (32) 755 (16) 1740 (38)

Polypectomy patients e 313 (2) 6 (2) 64 (20)

Missing 944 (7) 191 (20) 487 (52)

CRM f <3mm 1541 (11) 310 (20) 0.000 678 (44) 0.000

3-10 mm 1988 (14) 332 (17) 734 (37)

≥10 mm 5492 (38) 814 (15) 1798 (33)

Missing 5304 (37) 849 (16) 2130 (40)

LRM g <50 mm 4025 (28) 679 (17) 0.235 1527 (38) 0.001

5-90 mm 3383 (24) 513 (15) 1183 (35)

≥90mm 3652 (25) 596 (16) 1336 (37)

Missing 3265 (23) 517 (16) 1294 (40)

Mucinous No 10172 (71) 1607 (16) 0.308 3687 (36) 0.000

Yes 2690 (19) 448 (17) 1079 (40)

Missing 1463 (10) 250 (17) 574 (39)

Postoperative complications

No 10948 (76) 1724 (16) 0.044 3799 (35) 0.000

Yes 3377 (24) 581 (17) 1541 (46)

Adjuvant treatment

Stage I No adjuvant 2682 (98) 110 (4) 0.000 760 (28) 0.252

(2)

Adjuvant 48 (2) 10 (21) 10 (21) Stage II No adjuvant 5545 (88) 555 (10) 0.000 2014 (36) 0.000

Adjuvant 769 (12) 127 (17) 146 (19)

Stage III No adjuvant 2014 (39) 572 (28) 0.646 1369 (68) 0.000

Adjuvant 3187 (61) 924 (29) 1014 (32)

a Proportions tested with Pearsons-χ2 test.

b Region: Location of patient surgery.

c BMI: Body mass index.

d American Society of Anesthesiologists’ classification (ASA) rated by an anesthesiologist before surgery.

e Patients who underwent endoscopic polypectomy

f CRM: Circumferential resection margin

g LRM: Longitudinal resection margin.

Referensi

Dokumen terkait

Pada artikel ke-5 membahas mengenai pengembangan media pembelajaran e-learning berbasis edmodo twntang materi sel, diketahui bahwa media pembelajaran e-learning yang

1 Supplementary Table 2: Cumulative number of false-positive test results by age per 100 000 persons neoplasia-free at age 50 for various screening scenarios in the age range 50–74